{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ancillary+Study&page=85", "query": { "intervention": "Ancillary Study", "page": 85 }, "page_size": 10 }, "pagination": { "page": 85, "page_size": 10, "total_count": 2167, "total_pages": 217, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ancillary+Study&page=86&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ancillary+Study&page=84&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-02T18:22:56.403Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02921893", "title": "Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Plasmacytoma", "POEMS Syndrome" ], "interventions": [ { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Ixazomib Citrate", "type": "DRUG" }, { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 21, "start_date": "2016-10-31", "completion_date": "2024-05-13", "has_results": false, "last_update_posted_date": "2025-02-12", "last_synced_at": "2026-11-02T18:22:56.403Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02921893" }, { "nct_id": "NCT03184038", "title": "Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Metastatic Malignant Neoplasm in the Brain", "Metastatic Malignant Solid Neoplasm" ], "interventions": [ { "name": "Cognitive Assessment", "type": "PROCEDURE" }, { "name": "Stereotactic Radiosurgery", "type": "RADIATION" }, { "name": "Stereotactic Body Radiation Therapy", "type": "RADIATION" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "RADIATION", "OTHER" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2017-02-21", "completion_date": "2026-09-30", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-11-02T18:22:56.403Z", "location_count": 2, "location_summary": "Sewell, New Jersey • Philadelphia, Pennsylvania", "locations": [ { "city": "Sewell", "state": "New Jersey" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03184038" }, { "nct_id": "NCT01319526", "title": "Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lymphoma", "Nonneoplastic Condition" ], "interventions": [ { "name": "DNA analysis", "type": "GENETIC" }, { "name": "RNA analysis", "type": "GENETIC" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "GENETIC", "OTHER" ], "sponsor": "AIDS Malignancy Consortium", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2011-06", "completion_date": "2013-01", "has_results": false, "last_update_posted_date": "2020-07-29", "last_synced_at": "2026-11-02T18:22:56.403Z", "location_count": 2, "location_summary": "Baltimore, Maryland • Boston, Massachusetts", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01319526" }, { "nct_id": "NCT02250404", "title": "Molecular Signatures of Relapse in Tissue Samples From Patients With Small Cell Lung Cancer Who Are Receiving Cisplatin and Etoposide", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Small Cell Lung Cancer" ], "interventions": [ { "name": "cytology specimen collection procedure", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2014-08-22", "completion_date": "2019-08-22", "has_results": false, "last_update_posted_date": "2018-05-25", "last_synced_at": "2026-11-02T18:22:56.403Z", "location_count": 2, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02250404" }, { "nct_id": "NCT02909699", "title": "Cardiovascular Health of Older Adults and Resveratrol (CORE)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Aging" ], "interventions": [ { "name": "Observation", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "65 Years to 99 Years" }, "enrollment_count": 27, "start_date": "2016-11", "completion_date": "2018-03-31", "has_results": false, "last_update_posted_date": "2018-11-29", "last_synced_at": "2026-11-02T18:22:56.403Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02909699" }, { "nct_id": "NCT00436852", "title": "ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Disseminated Neuroblastoma", "Recurrent Neuroblastoma" ], "interventions": [ { "name": "ABT-751", "type": "DRUG" }, { "name": "quality-of-life assessment", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 92, "start_date": "2007-01", "completion_date": "2015-03-30", "has_results": true, "last_update_posted_date": "2019-07-17", "last_synced_at": "2026-11-02T18:22:56.403Z", "location_count": 11, "location_summary": "Birmingham, Alabama • Chicago, Illinois • Boston, Massachusetts + 8 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00436852" }, { "nct_id": "NCT04186884", "title": "Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Advanced Malignant Neoplasm", "Locally Advanced Malignant Neoplasm", "Metastatic Malignant Neoplasm", "Recurrent Malignant Neoplasm" ], "interventions": [ { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 351, "start_date": "2019-03-26", "completion_date": "2021-11-05", "has_results": false, "last_update_posted_date": "2022-03-03", "last_synced_at": "2026-11-02T18:22:56.403Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04186884" }, { "nct_id": "NCT04530812", "title": "Fermented Milk Supplementation on Symptoms of Disease and Treatment in Patients With Multiple Myeloma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Plasma Cell Myeloma" ], "interventions": [ { "name": "Best Practice", "type": "OTHER" }, { "name": "Kefir", "type": "DIETARY_SUPPLEMENT" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DIETARY_SUPPLEMENT" ], "sponsor": "Roswell Park Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 13, "start_date": "2020-08-24", "completion_date": "2021-08-30", "has_results": false, "last_update_posted_date": "2021-11-16", "last_synced_at": "2026-11-02T18:22:56.403Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04530812" }, { "nct_id": "NCT02408406", "title": "PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bladder Carcinoma", "Breast Carcinoma", "Colorectal Carcinoma", "Lung Carcinoma", "Malignant Female Reproductive System Neoplasm", "Malignant Neoplasm" ], "interventions": [ { "name": "Communication Intervention", "type": "OTHER" }, { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Internet-Based Intervention", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 140, "start_date": "2015-07-07", "completion_date": "2024-06-19", "has_results": false, "last_update_posted_date": "2024-06-27", "last_synced_at": "2026-11-02T18:22:56.403Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02408406" }, { "nct_id": "NCT04711109", "title": "Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "BRCA1 Mutation", "Breast Cancer", "Breast Diseases", "Breast Neoplasms", "Breast Carcinoma", "Neoplasms" ], "interventions": [ { "name": "Denosumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "25 Years to 55 Years · Female only" }, "enrollment_count": 300, "start_date": "2023-02-14", "completion_date": "2033-12", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-11-02T18:22:56.403Z", "location_count": 47, "location_summary": "Los Angeles, California • San Francisco, California • Aurora, Colorado + 38 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boulder", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04711109" } ] }